Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.141
Neutral
RSI(14)
52.381
Neutral
STOCH(KDJ)(9,3,3)
23.633
Sell
ATR(14)
0.384
Low Volatility
CCI(14)
-159.056
Sell
Williams %R
78.641
Sell
TRIX(12,20)
0.323
Sell
StochRSI(14)
0.000
Oversold
AngioDynamics Inc
ANGO13.100USD
-0.060-0.46%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
542.95MMarket Cap
LossP/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of AngioDynamics Inc
Currency: USD Updated: 2025-12-26Key Insights
AngioDynamics Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 24/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 18.50.In the medium term, the stock price is expected to trend up.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
AngioDynamics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Buy
Current Rating
18.500
Target Price
+39.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
AngioDynamics Inc Highlights
StrengthsRisks
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
Undervalued
The company’s latest PE is -16.75, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 40.19M shares, decreasing 0.03% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 3.91K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.36.
Financial Health
Currency: USD Updated: 2025-12-26The current financial score of AngioDynamics Inc is 7.52, ranking 74/207 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 75.71M, representing a year-over-year increase of 12.18%, while its net profit experienced a year-over-year increase of 14.81%.
Score
Financials
6.59
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
10.00
Operational Efficiency
6.03
Growth Potential
8.45
Shareholder Returns
6.52
AngioDynamics Inc's Company Valuation
Currency: USD Updated: 2025-12-26The current valuation score of AngioDynamics Inc is 7.26, ranking 104/207 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -16.75, which is -410.89% below the recent high of 52.08 and -32.51% above the recent low of -22.20.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 24/207
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-26The current earnings forecast score of AngioDynamics Inc is 8.50, ranking 30/207 in the Healthcare Equipment & Supplies industry. The average price target for AngioDynamics Inc is 17.00, with a high of 24.00 and a low of 16.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
18.500
Target Price
+39.52%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
112
Total
6
Median
9
Average
Company name
Ratings
Analysts
AngioDynamics Inc
ANGO
4
Medtronic PLC
MDT
35
Stryker Corp
SYK
32
Dexcom Inc
DXCM
31
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
1
2
3
...
23
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-26The current price momentum score of AngioDynamics Inc is 7.31, ranking 57/207 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 13.98 and the support level at 12.23, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
13.286
Sell
MA10
13.283
Sell
MA20
13.267
Sell
MA50
12.538
Buy
MA100
11.417
Buy
MA200
10.506
Buy
Institutional Confidence
Currency: USD Updated: 2025-12-26The current institutional shareholding score of AngioDynamics Inc is 10.00, ranking 1/207 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 106.71%, representing a quarter-over-quarter decrease of 2.15%. The largest institutional shareholder is Steven Cohen, holding a total of 2.56M shares, representing 6.21% of shares outstanding, with 171.58% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
Divisadero Street Capital Management, LP
BlackRock Institutional Trust Company, N.A.
Systematic Financial Management, L.P.
Millennium Management LLC
Armistice Capital LLC
Segall Bryant & Hamill, LLC
Bastion Asset Management Inc.
Dimensional Fund Advisors, L.P.
1
2
Risk Assessment
Currency: USD Updated: 2025-12-26The current risk assessment score of AngioDynamics Inc is 7.10, ranking 43/207 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.47. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.47
VaR
+4.21%
240-Day Maximum Drawdown
+34.46%
240-Day Volatility
+55.40%
Return
Best Daily Return
60 days
+6.05%
120 days
+6.05%
5 years
+37.66%
Worst Daily Return
60 days
-4.12%
120 days
-10.18%
5 years
-27.02%
Sharpe Ratio
60 days
+2.14
120 days
+2.26
5 years
+0.04
Risk Assessment
Maximum Drawdown
240 days
+34.46%
3 years
+60.26%
5 years
+82.98%
Return-to-Drawdown Ratio
240 days
+0.15
3 years
+0.00
5 years
-0.10
Skewness
240 days
+0.38
3 years
+1.66
5 years
+1.15
Volatility
Realised Volatility
240 days
+55.40%
5 years
+55.88%
Standardised True Range
240 days
+3.56%
5 years
+4.63%
Downside Risk-Adjusted Return
120 days
+322.28%
240 days
+322.28%
Maximum Daily Upside Volatility
60 days
+37.09%
Maximum Daily Downside Volatility
60 days
+21.92%
Liquidity
Average Turnover Rate
60 days
+1.48%
120 days
+1.40%
5 years
--
Turnover Deviation
20 days
-36.48%
60 days
+6.97%
120 days
+0.99%
Peer Comparison
Healthcare Equipment & Supplies
AngioDynamics Inc
ANGO
7.84 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Edwards Lifesciences Corp
EW
8.72 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Artivion Inc
AORT
8.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.48 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Tactile Systems Technology Inc
TCMD
8.47 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AxoGen Inc
AXGN
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of AngioDynamics Inc?
The TradingKey Stock Score provides a comprehensive assessment of AngioDynamics Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of AngioDynamics Inc’s performance and outlook.
How do we generate the financial health score of AngioDynamics Inc?
To generate the financial health score of AngioDynamics Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects AngioDynamics Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of AngioDynamics Inc.
How do we generate the company valuation score of AngioDynamics Inc?
To generate the company valuation score of AngioDynamics Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare AngioDynamics Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of AngioDynamics Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of AngioDynamics Inc.
How do we generate the earnings forecast score of AngioDynamics Inc?
To calculate the earnings forecast score of AngioDynamics Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on AngioDynamics Inc’s future.
How do we generate the price momentum score of AngioDynamics Inc?
When generating the price momentum score for AngioDynamics Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of AngioDynamics Inc’s prices. A higher score indicates a more stable short-term price trend for AngioDynamics Inc.
How do we generate the institutional confidence score of AngioDynamics Inc?
To generate the institutional confidence score of AngioDynamics Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about AngioDynamics Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of AngioDynamics Inc.
How do we generate the risk management score of AngioDynamics Inc?
To assess the risk management score of AngioDynamics Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of AngioDynamics Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of AngioDynamics Inc.
